Literature DB >> 35583726

Time to Reconsider Routine Timely Anti-epileptic Medication: Raising Hope with a "Smart" Nanoengineered System.

Yingying Tang1, Jianan Quan2, Weijie Zhou2, Haoliang Zhou2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35583726      PMCID： PMC9352823          DOI： 10.1007/s12264-022-00874-1

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN： 1995-8218            Impact factor:   5.271


× No keyword cloud information.
  10 in total

1.  Low-frequency Stimulation at the Subiculum is Anti-convulsant and Anti-drug-resistant in a Mouse Model of Lamotrigine-resistant Temporal Lobe Epilepsy.

Authors:  Yeping Ruan; Cenglin Xu; Jile Lan; Jiazhen Nao; Shuo Zhang; Fei Fan; Yi Wang; Zhong Chen
Journal:  Neurosci Bull       Date:  2020-03-10       Impact factor: 5.203

Review 2.  New avenues for anti-epileptic drug discovery and development.

Authors:  Wolfgang Löscher; Henrik Klitgaard; Roy E Twyman; Dieter Schmidt
Journal:  Nat Rev Drug Discov       Date:  2013-09-20       Impact factor: 84.694

3.  Angiopep-conjugated electro-responsive hydrogel nanoparticles: therapeutic potential for epilepsy.

Authors:  Xiaoying Ying; Yi Wang; Jiao Liang; Jiaxing Yue; Cenglin Xu; Lina Lu; Zhenghao Xu; Jianqing Gao; Yongzhong Du; Zhong Chen
Journal:  Angew Chem Int Ed Engl       Date:  2014-07-18       Impact factor: 15.336

4.  Phenolic-enabled nanotechnology: versatile particle engineering for biomedicine.

Authors:  Di Wu; Jiajing Zhou; Matthew N Creyer; Wonjun Yim; Zhong Chen; Phillip B Messersmith; Jesse V Jokerst
Journal:  Chem Soc Rev       Date:  2021-02-17       Impact factor: 54.564

Review 5.  New advances in pharmacoresistant epilepsy towards precise management-from prognosis to treatments.

Authors:  Cenglin Xu; Yiwei Gong; Yi Wang; Zhong Chen
Journal:  Pharmacol Ther       Date:  2021-10-28       Impact factor: 12.310

6.  Electroresponsive Nanoparticles Improve Antiseizure Effect of Phenytoin in Generalized Tonic-Clonic Seizures.

Authors:  Yi Wang; Xiaoying Ying; Liying Chen; Yao Liu; Ying Wang; Jiao Liang; Cenglin Xu; Yi Guo; Shuang Wang; Weiwei Hu; Yongzhong Du; Zhong Chen
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

7.  Subicular caspase-1 contributes to pharmacoresistance in temporal lobe epilepsy.

Authors:  Cenglin Xu; Shuo Zhang; Yiwei Gong; Jiazhen Nao; Yujia Shen; Bei Tan; Shuheng Xu; Sunliang Cui; Yeping Ruan; Shuang Wang; Yi Wang; Zhong Chen
Journal:  Ann Neurol       Date:  2021-07-20       Impact factor: 10.422

8.  A sensitive and specific nanosensor for monitoring extracellular potassium levels in the brain.

Authors:  Jianan Liu; Fangyuan Li; Yi Wang; Limin Pan; Peihua Lin; Bo Zhang; Yanrong Zheng; Yingwei Xu; Hongwei Liao; Giho Ko; Fan Fei; Cenglin Xu; Yang Du; Kwangsoo Shin; Dokyoon Kim; Sung-Soo Jang; Hee Jung Chung; He Tian; Qi Wang; Wei Guo; Jwa-Min Nam; Zhong Chen; Taeghwan Hyeon; Daishun Ling
Journal:  Nat Nanotechnol       Date:  2020-02-10       Impact factor: 39.213

9.  Patterns of treatment response in newly diagnosed epilepsy.

Authors:  M J Brodie; S J E Barry; G A Bamagous; J D Norrie; P Kwan
Journal:  Neurology       Date:  2012-05-09       Impact factor: 9.910

10.  Nanoengineered on-demand drug delivery system improves efficacy of pharmacotherapy for epilepsy.

Authors:  Di Wu; Fan Fei; Qi Zhang; Xia Wang; Yiwei Gong; Xiaojie Chen; Yuyi Zheng; Bei Tan; Cenglin Xu; Hujun Xie; Wenjun Fang; Zhong Chen; Yi Wang
Journal:  Sci Adv       Date:  2022-01-12       Impact factor: 14.136
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.